Exploring Unanswered Questions on CAR-T Cell Therapy in Myeloma – Curetoday.com
|
Exploring Unanswered Questions on CAR–T Cell Therapy in Myeloma
Curetoday.com The success of CAR– (chimeric antigen receptor) T cell therapy is causing landmark change in the way that patients with multiple myeloma are being treated, but more research needs to be done to better understand the role that these agents will play. BY … |
